Apple Heart Care and Research Institute a premier research institute in the field of Preventive & Rehabilitative Non- Invasive Cardiology in Mumbai announced its expansion plan.
Dr Manish Motwani, Director of Apple Heart Care announced that Apple is planning to set up 50 more centers across the country in next two years time. The primary objective of the institute is to prevent the epidemic of killer heart disease in all possible ways by reaching out to every individuals in the country who is in need of life style modification to prevent the occurrence of the disease, and also to prevent the reoccurrence to the people already effected with the disease and undergone surgeries or living with medications.
S Senthil Kandeepan, CEO, CHC Group while talking on the expansion plan invited all the like minded Health Care Institutions to join hands with Apple Heart Care as project partners, he also revealed that Apple is likely to join hands with some of the top most heart care institutions in near future to make the services of Apple available in all the major cities in the country including the 4 metros cities in which Apple has its operation in two of the metros already.
Extentrac India signs an exclusive distribution contract
Date:
2nd June, 2009
New Delhi
Extentrac India signs an exclusive distribution contract with Advanced Back Technologies, Inc., U.S.A., to market and distribute Extentrac Elite exclusively in India, Extentrac is a revolutionary therapeutic devices for back and neck pain. With the incorporation of its patented M3D spinal positioning technology, Extentrac Elite has become an undisputed leader in this line of Therapy.
Advanced Back Technologies, has its manufacturing plant, located in Hauppauge, New York, whose Management System is certified as being in conformity with ISO 13485. Its continued design innovation has lead to numerous United States and International patents. ExtenTrac® Elite has also got US FDA clearance.
Dr. David F. Cuccia, President of Advance Back Technologies Inc., USA while signing the agreement with Extentrac India said that associating with CHC group of companies gives him great confidence for their success in India he assured to the Indian market that his company would be committed to give its best to the Indian market in collaboration with Extentrac India.
Mr. S Senthil Kandeepan CEO of CHC Group was delighted to sign the agreement with Advance Back Technologies, he said, “Technology is not the same everyday, it only advances; by introducing Extentrac Elite to India, I feel great pride in introducing yet another technology to the Indian Heath Care sector.
He asserted that Extentrac India, will make all its efforts to make this technology available to all the need people out in all the corners of the country.
CHC announces its all india Toll free no.
Date: 1st April, 2009
New Delhi
CHC Group Introduces, All India Toll free number to service its clients much better and faster. 1800 11 33 22 the toll free number from MTNL can be called from any Fixed line or Mobile phone at free of cost from any part of India.
While introducing the number Mr S Senthil Kandeepan CEO, of CHC Group said that, this unique initiative by CHC is going to service the CHC clients in a larger way, they can contact the CHC representative any time without paying for it. The toll free number over a period of time would be a one stop solution for all the health care needs.
All the CHC group companies which includes, Cardiopulse Heart Care, Extentrac India, Apple Heart Care and Research Institute, Hiify Health and Life Style Magazine, Spectrum India Health Care Consultancies & CHC Herbalaya would be served through the toll free number.
Dr Edayarajan, Medical Director - Irudayam Hospitals while appreciating the efforts of CHC said that, it’s a very good initiative what CHC has taken at a time when such unique services is required to give the finest and timely services to the mounting health care sector in India.
